RAKUTEN MEDICAL, INC.

Profile

Company Names

RAKUTEN MEDICAL, INC.
RAKUTEN ASPYRIAN, INC.
ASPYRIAN THERAPEUTICS, INC.

Addresses

6885 FLANDERS DRIVE, SUITE 100, SAN DIEGO, CA 92121

6885 FLANDERS DRIVE SUITE 100, SAN DIEGO, CA 92121

11080 ROSELLE STREET, SUITE 400, SAN DIEGO, CA 92121

900 CONCAR DR., SUITE 200, SAN MATEO, CA 94402

900 CONCAR DRIVE #200, SAN MATEO, CA 94402

900 CONCAR DR., SUITE 400, SAN MATEO, CA 94402

11080 ROSELLE STREET, SAN DIEGO, CA 92121

10581 ROSELLE STREET, SUITE 115, SAN DIEGO, CA 92121

11189 SORRENTO VALLEY RD. STE 104, SAN DIEGO, CA 92121

Phone Numbers

833-725-8633
(833) 725-8633
858-925-5619
858-784-9098

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2010

State Incorporated:

DELAWARE

Total Amount Raised:

$899,341,791.00

Number of Funding Rounds:

16
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
16
2025-07-11 
$111,522,289.00 
$116,672,752.00 
$5,150,463.00 
Equity 
15
2024-12-12 
$1,865,406.00 
$1,865,406.00 
$0.00 
 
14
2024-03-13 
$4,161,200.00 
$4,161,200.00 
$0.00 
 
13
2023-08-18 
$104,816,348.00 
$123,689,146.00 
$18,872,798.00 
Equity 
12
2022-12-16 
$70,000,000.00 
$90,000,000.00 
$20,000,000.00 
Debt 
11
2022-06-23 
$2,189,000.00 
$2,189,000.00 
$0.00 
 
10
2021-07-16 
$166,010,712.00 
$291,010,708.00 
$124,999,996.00 
Equity 
9
2020-12-31 
$15,000,000.00 
$15,000,000.00 
$0.00 
Equity 
8
2020-12-23 
$90,000,000.00 
$90,000,000.00 
$0.00 
Debt 
7
2020-07-01 
$791,700.00 
$791,700.00 
$0.00 
Equity 
6
2019-07-31 
$99,999,997.00 
$99,999,997.00 
$0.00 
Equity 
5
2018-08-10 
$149,999,993.00 
$350,000,001.00 
$200,000,008.00 
Equity 
4
2017-07-07 
$15,079,974.00 
$19,000,000.00 
$3,920,026.00 
Equity 
3
2016-02-24 
$55,199,998.00 
$56,049,999.00 
$850,001.00 
Equity 
2
2015-07-17 
$4,249,999.00 
$4,249,999.00 
$0.00 
Equity 
1
2014-12-05 
$8,455,175.00 
$8,455,175.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ABHIJIT 
 
BHATIA 
EXECUTIVE OFFICER
MERRILL 
 
BIEL 
EXECUTIVE OFFICER, DIRECTOR
MAZEN 
 
DARWAZAH 
DIRECTOR
MAZEN 
 
DARWAZEH 
DIRECTOR
MIGUEL 
 
GARCIA-GUZMAN 
DIRECTOR, EXECUTIVE OFFICER
KENTARO 
 
HYAKUNO 
DIRECTOR
DANA 
 
JOHNSON 
EXECUTIVE OFFICER
EIICHI 
 
KAGA 
DIRECTOR
BRENTON 
 
KEATH 
EXECUTIVE OFFICER
HIROYUKI 
 
KODAMA 
EXECUTIVE OFFICER
MINAMI 
 
MAEDA 
EXECUTIVE OFFICER
AGATHA 
 
MARTINDALE 
EXECUTIVE OFFICER
ANN 
 
MCGUIRE 
EXECUTIVE OFFICER
HIROSHI 
 
MIKITANI 
DIRECTOR, EXECUTIVE OFFICER
MAEDA 
 
MINAMI 
EXECUTIVE OFFICER
HIROSHI 
 
MORI 
DIRECTOR
NITIN 
 
NOHRIA 
DIRECTOR
TIFFANY 
 
PIECEWICZ 
EXECUTIVE OFFICER
SCOTT 
 
SALKA 
EXECUTIVE OFFICER, DIRECTOR
SUZANE 
 
SAN 
EXECUTIVE OFFICER
TOSHIAKI 
 
SUZUKI 
EXECUTIVE OFFICER
HIROSHI 
 
TAKASAWA 
DIRECTOR
TAKASHI 
 
TORAISHI 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-07-11 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2024-12-12 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2024-12-12 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2024-03-13 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2022-06-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-08-18 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-12-16 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2022-06-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-16 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-12-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-01 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-31 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-10 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-10 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-10 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-07 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-24 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-24 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
MOMENTUM CAPITAL MARKETS, LLC
NONE
NONE
TAP SECURITIES LLC